NEW YORK, March 29, 2017 -- Dr. Mark S. Granick, Professor and Chief of Plastic Surgery at Rutgers New Jersey Medical School has been selected to join the Education Board at the American Health Council. He will be sharing his knowledge and expertise on Plastic Surgery and Reconstructive Surgery.
A Fellow of the American College of Surgeons, Dr. Granick utilizes his four decades of experience in the field of Plastic Surgery in his role as the Professor and Chief of Plastic Surgery at Rutgers New Jersey Medical School (NJMS). Established in 1954, the Rutgers New Jersey Medical School prides itself on educating students, physicians, and scientists to meet society’s current and future healthcare needs through patient-centered education; pioneering research; innovative clinical, rehabilitative and preventive care; and collaborative community outreach.
As the Professor and Chief of Plastic Surgery at Rutgers New Jersey Medical School since 2001, Dr. Granick’s day-to-day responsibilities include research, teaching and clinical plastic surgery. He has authored over 150 peer reviewed publications, edited 9 textbooks, and has written over 50 book chapters. Dr. Granick serves as one of the Founders and on the Executive Board of the Journal of Wound Technology. He has received NIH grant funding on biofilm research.
Following graduation with his medical degree from the Harvard Medical School in 1977, Dr. Granick pursued a residency in surgery at the Beth Israel Deacones Medical Center in 1978. He went on to complete a residency in otolaryngology at the Massachusetts Eye and Ear Infirmary in 1982. Dr. Granick completed a residency in plastic surgery at the University of Pittsburgh Medical Center in 1984. He is certified by the American Board of Otolaryngology, Head and Neck Surgery and the American Board of Plastic Surgery.
Though initially interested in ENT (Ear, Nose, and Throat) because of the wide-ranging spectrum of the head and neck pathology, Dr. Granick opted for the field of plastic surgery because the nature of plastic surgery is to use the principles of surgery in a creative fashion to individualize treatment for each patient. Looking back, he measures his success by the number and competence of residents he has trained. Dr. Granick attributes his personal success to continuously learning, outstanding training opportunities, and persistence.
Dr. Granick maintains a membership with The American Association of Plastic Surgery, The New Jersey Society Plastic Surgeons, The Northeastern Society of Plastic Surgeons, the American Society of Plastic Surgeons, and The Wound Healing Society.
As a testament to his success, Dr. Granick has been honored with The Global Live-Wire Medical Award for Best Clinician in the United States, the Best of New York/Best of New Jersey – 25+ times by Castle Connolly, and has been named the 2016 and 2017 Top Plastic Surgeon in New Jersey by the International Association of Plastic Surgeons
Considering the future, Dr. Granick hopes to expand the clinical practice and continue to improve his residency training program at Rutgers New Jersey Medical School.
For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: [email protected]


Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
AFT Leaves X Over AI-Generated Images of Minors
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules 



